Membrane polarity: a target for myocardial protection and reduced inflammation in adult and pediatric cardiothoracic surgery.
Dobson
Geoffrey P
GP
D000241:Adenosine / Q000494:pharmacology; D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D006348:Cardiac Surgical Procedures; D002314:Cardioplegic Solutions / Q000009:adverse effects* / Q000737:chemistry; D002318:Cardiovascular Diseases / Q000378:metabolism / Q000601:surgery*; D002648:Child; D004730:Endothelium, Vascular / Q000473:pathology*; D006324:Heart Arrest, Induced / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D006947:Hyperkalemia / Q000209:etiology* / Q000378:metabolism; D007249:Inflammation / Q000209:etiology* / Q000378:metabolism; D008012:Lidocaine / Q000494:pharmacology; D008564:Membrane Potentials / Q000502:physiology*; D009206:Myocardium / Q000473:pathology*; D011183:Postoperative Complications; D011188:Potassium / Q000009:adverse effects* / Q000378:metabolism; D012307:Risk Factors
D000889:Anti-Arrhythmia Agents; D002314:Cardioplegic Solutions; D008012:Lidocaine; D000241:Adenosine; D011188:Potassium